Treatment of High-Risk Neuroblastoma in a Southeast Asian Hub of Medical Tourism

被引：0
|
作者：
Lee, A. [1 ]
Chui, C. H. [2 ]
Aung, L. [1 ]
Wong, W. [3 ]
机构：
[1] Mt Elizabeth Hosp, Childrens Haematol & Canc Ctr, Singapore, Singapore
[2] Mt Elizabeth Med Ctr, Surg Ctr Children, Singapore, Singapore
[3] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-375
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [41] Molecular aberrations in non-high risk neuroblastoma progressing to high-risk neuroblastoma
    Bruinsma, R.
    Dierselhuis, M.
    de Leng, W.
    Kester, L.
    van Noesel, M.
    Tytgat, L.
    van de Ven, K.
    Wijnen, M.
    de Krijger, R.
    van der Steeg, L.
    VIRCHOWS ARCHIV, 2024, 485 : S324 - S324
  • [42] Isotretinoin-induced psychosis in a child on treatment for high-risk neuroblastoma
    Greenwell, Alyssa M. M.
    Gorsi, Hamza S. S.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (04)
  • [43] Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
    Keyel, Michelle E.
    Reynolds, C. Patrick
    BIOLOGICS-TARGETS & THERAPY, 2019, 13 : 1 - 12
  • [44] Treatment of high-risk neuroblastoma with anti-GD2 antibodies
    Castel, Victoria
    Segura, Vanessa
    Canete, Adela
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (12): : 788 - 793
  • [45] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [46] Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma
    Hill-Kayser, Christine E.
    Tochner, Zelig
    Li, Yimei
    Kurtz, Goldie
    Lustig, Robert A.
    James, Paul
    Balamuth, Naomi
    Womer, Richard
    Mattei, Peter
    Grupp, Stephen
    Mosse, Yael P.
    Maris, John M.
    Bagatell, Rochelle
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (02): : 401 - 408
  • [47] RESULTS OF TREATMENT OF PATIENTS WITH NEUROBLASTOMA STAGE 3 HIGH-RISK GROUPS
    Hizhnikov, A.
    Anatoly, K.
    Polad, K.
    Michael, R.
    Marina, R.
    Olga, K.
    Diana, R.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S330 - S330
  • [48] Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma
    Bartholomew, Joy
    Washington, Tanea
    Bergeron, Sharon
    Nielson, Danelle
    Saggio, Jennifer
    Quirk, Lindsay
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2017, 34 (01) : 5 - 12
  • [49] Surgical challenges associated with intensive treatment protocols for high-risk neuroblastoma
    Cantos, Mae F.
    Gerstle, J. Ted
    Irwin, Meredith S.
    Pappo, Alberto
    Farley, Shannon
    Cheang, Timothy
    Kim, Peter C. W.
    JOURNAL OF PEDIATRIC SURGERY, 2006, 41 (05) : 960 - 965
  • [50] Treatment of high-risk neuroblastoma with anti-GD2 antibodies
    Victoria Castel
    Vanessa Segura
    Adela Cañete
    Clinical and Translational Oncology, 2010, 12 : 788 - 793
12345